US Stock MarketDetailed Quotes
MRKR Marker Therapeutics
- 3.0508
- +0.1208+4.12%
Trading Nov 19 12:01 ET
27.22MMarket Cap-2798P/E (TTM)
3.1100High2.9200Low8.25KVolume2.9200Open2.9300Pre Close25.05KTurnover0.12%Turnover RatioLossP/E (Static)8.92MShares6.156852wk High3.65P/B20.63MFloat Cap2.437752wk Low--Dividend TTM6.76MShs Float2447.9980Historical High--Div YieldTTM6.49%Amplitude0.6700Historical Low3.0350Avg Price1Lot Size
About Marker Therapeutics Company
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Company Profile
SymbolMRKR
Company NameMarker Therapeutics
Listing DateNov 7, 2016
Founded1991
CEODr. Juan Vera, M.D.
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address2450 Holcombe Boulevard,Suite BCM-A, MS: BCM251
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77021
Phone1-713-400-6400
Company Executives
- Name
- Position
- Salary
- Dr. Juan Vera, M.D.
- Director, President, Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer
- 585.25K
- N. David Eansor
- Chairman of the Board
- 124.04K
- Dr. Katharine Knobil, M.D.
- Independent Director
- 79.67K
- Steven A. Elms
- Independent Director
- 76.14K
- John Wilson
- Independent Director
- 63.44K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data